Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „majority“
Suchtreffer
Begriffe & Kennungen
Ocrevus · 4.8 · 43 The majority of these decreases reported in intravenous ocrelizumab treated patients were Grade 1 (<LLN – 8
Eintrag öffnenOcrevus · 4.8 · The majority of the neutrophil decreases were transient (only observed once for a given patient treated with o
Eintrag öffnenOcrevus · 4.8 · The majority of the neutrophil decreases were transient (only observed once for a given patient treated with o
Eintrag öffnenOcrevus · 4.8 · The majority of these decreases reported in ocrelizumab treated patients were Grade 1 (<LLN - 800 cells/mm3) a
Eintrag öffnenOngentys · 4.5 · Combination of opicapone and MAO inhibitors could result in inhibition of the majority of the pathways respons
Eintrag öffnenOprymea · 4.8 · 34 The majority of adverse drug reactions usually start early in therapy and most tend to disappear even as th
Eintrag öffnenOprymea · 4.8 · The majority of adverse drug reactions usually start early in therapy and most tend to disappear even as thera
Eintrag öffnenOprymea · 4.8 · The majority of adverse drug reactions usually start early in therapy and most tend to disappear even as thera
Eintrag öffnenOzempic · 4.8 · In a 40-week phase 3b trial in patients receiving semaglutide 1 mg and 2 mg, the majority of the hypoglycaemic
Eintrag öffnenPerjeta · 4.8 · 11 Febrile neutropenia In the pivotal trial CLEOPATRA, the majority of patients in both treatment groups exper
Eintrag öffnenPerjeta · 4.8 · Overall, the majority of hypersensitivity reactions were mild or moderate in severity and resolved upon treatm
Eintrag öffnenPhesgo · 4.8 · In the pivotal trial CLEOPATRA, the majority of patients in both treatment groups experienced at least one leu
Eintrag öffnenPhesgo · 4.8 · Overall, the majority of hypersensitivity reactions were mild or moderate in severity and resolved upon treatm
Eintrag öffnenPoherdy · 4.8 · Febrile neutropenia In the pivotal trial CLEOPATRA, the majority of patients in both treatment groups experien
Eintrag öffnenPoherdy · 4.8 · Overall, the majority of hypersensitivity reactions were mild or moderate in severity and resolved upon treatm
Eintrag öffnenPombiliti · 4.8 · The majority of ERT-experienced and ERT-naïve subjects treated with cipaglucosidase alfa were positive post-tr
Eintrag öffnenPramipexole Teva · 4.8 · The majority of adverse drug reactions usually start early in therapy and most tend to disappear even as thera
Eintrag öffnenQuviviq · 4.8 · 7 The majority of adverse reactions were mild to moderate in intensity. No evidence of a dose- relationship fo
Eintrag öffnenRebif · 4.8 · The majority of adverse reactions observed with interferon beta-1a are usually mild and reversible, and respon
Eintrag öffnenRebif · 4.8 · The majority of adverse reactions observed with interferon beta-1a are usually mild and reversible, and respon
Eintrag öffnen